Published in Int J Cancer on December 21, 2011
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b. PLoS One (2013) 0.87
Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome. Br J Cancer (2012) 0.82
Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis. BMC Genomics (2015) 0.78
Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling. Sci Rep (2017) 0.77
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers. Oncologist (2015) 0.76
BARD1 mediates TGF-β signaling in pulmonary fibrosis. Respir Res (2015) 0.76
Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC. Open Med (Wars) (2016) 0.75
Cancer-risk module identification and module-based disease risk evaluation: a case study on lung cancer. PLoS One (2014) 0.75
Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability. Oncotarget (2016) 0.75
BARD1 serum autoantibodies for the detection of lung cancer. PLoS One (2017) 0.75
Deployment of distributed applications in wireless sensor networks. Sensors (Basel) (2011) 3.53
Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol (2002) 2.84
Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med (2004) 2.80
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med (2002) 2.51
Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest (2006) 2.40
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol (2005) 2.39
Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol (2003) 2.14
Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol (2005) 2.05
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 1.97
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest (2009) 1.96
Diagnosis of anal sphincter tears to prevent fecal incontinence: a randomized controlled trial. Obstet Gynecol (2005) 1.61
Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol (2004) 1.56
Effect of silibinin on the growth and progression of primary lung tumors in mice. J Natl Cancer Inst (2006) 1.55
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol (2005) 1.53
Metabolomics as a tool for cardiac research. Nat Rev Cardiol (2011) 1.51
Mechanical methods for induction of labour. Cochrane Database Syst Rev (2012) 1.47
Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 1.46
Clara cell: progenitor for the bronchiolar epithelium. Int J Biochem Cell Biol (2009) 1.46
Repeat digital cervical assessment in pregnancy for identifying women at risk of preterm labour. Cochrane Database Syst Rev (2010) 1.43
Incidence of early neonatal mortality and morbidity after late-preterm and term cesarean delivery. Pediatrics (2009) 1.40
Mutational spectrum of p53 mutations in primary breast and ovarian tumors. Crit Rev Oncol Hematol (2004) 1.39
Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol (2010) 1.35
Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc (2006) 1.35
Risk factors for pelvic organ prolapse repair after hysterectomy. Obstet Gynecol (2007) 1.32
Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing. Mol Carcinog (2004) 1.32
Mechanisms of chromosome instability in cancers. Crit Rev Oncol Hematol (2006) 1.31
Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res (2002) 1.31
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol (2003) 1.27
The human cytotrophoblastic cell, a mononuclear chameleon. Int J Biochem Cell Biol (2005) 1.24
Physical activity and pregnancy: cardiovascular adaptations, recommendations and pregnancy outcomes. Sports Med (2010) 1.24
Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis. J Natl Cancer Inst (2005) 1.21
Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am J Pathol (2010) 1.16
Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res (2002) 1.16
Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis (2004) 1.16
Complications associated with transobturator sling procedures: analysis of 233 consecutive cases with a 27 months follow-up. BMC Womens Health (2009) 1.14
Women's health 18 years after rupture of the anal sphincter during childbirth: II. Urinary incontinence, sexual function, and physical and mental health. Am J Obstet Gynecol (2006) 1.14
Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev (2010) 1.14
Women's health 18 years after rupture of the anal sphincter during childbirth: I. Fecal incontinence. Am J Obstet Gynecol (2006) 1.14
FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Oncol Rep (2005) 1.14
Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol (2007) 1.13
Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice. Am J Pathol (2007) 1.13
Effects of recommended levels of physical activity on pregnancy outcomes. Am J Obstet Gynecol (2009) 1.12
Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2. Cancer Res (2009) 1.12
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Cancer Res (2012) 1.09
Differential roles of extracellular signal-regulated kinase 1/2 and p38MAPK in mechanical load-induced procollagen alpha1(I) gene expression in cardiac fibroblasts. Cardiovasc Res (2004) 1.09
Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst Rev (2011) 1.08
Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.08
Feasibility and safety study of a new device (Odón device) for assisted vaginal deliveries: study protocol. Reprod Health (2013) 1.08
How to report and interpret fetal mortality. Am J Obstet Gynecol (2013) 1.08
MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res (2011) 1.07
Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med (2011) 1.07
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med (2012) 1.07
Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am J Physiol Lung Cell Mol Physiol (2004) 1.05
Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity. J Biol Chem (2003) 1.04
BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase. Oncogene (2005) 1.03
Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Cancer Res (2003) 1.03
Nonclosure of the peritoneum during caesarean section: long-term follow-up of a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol (2003) 1.02
Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Womens Health (2011) 1.02
Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) (2009) 1.02
Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells. Mol Carcinog (2011) 1.02
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice. Cancer Chemother Pharmacol (2007) 1.01
Adiponectin affects lung epithelial A549 cell viability counteracting TNFα and IL-1ß toxicity through AdipoR1. Int J Biochem Cell Biol (2013) 1.01
Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int J Biochem Cell Biol (2012) 1.01
Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections. Cancer Lett (2003) 1.01
Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins. Int J Mol Sci (2013) 1.00
Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies. Clin Cancer Res (2010) 1.00
Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci (2002) 1.00
Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res (2004) 0.99
A macrophage gene expression signature defines a field effect in the lung tumor microenvironment. Cancer Res (2008) 0.99
Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev (2013) 0.99
Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity. Oncogene (2004) 0.98
Metabolomics application in maternal-fetal medicine. Biomed Res Int (2013) 0.98
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis. Int J Cancer (2006) 0.98
Care of women with female genital mutilation/cutting. Swiss Med Wkly (2011) 0.97
Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis. Cancer Lett (2005) 0.97
Telomere length and ApoE polymorphism in mild cognitive impairment, degenerative and vascular dementia. J Neurol Sci (2010) 0.97
Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to tumour size and histology. Med Sci Monit (2013) 0.96
Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol (2002) 0.96
Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy. Cancer Res (2004) 0.96
Oncogenic BARD1 isoforms expressed in gynecological cancers. Cancer Res (2007) 0.95
Antibiotics for preterm rupture of the membranes: a systematic review. Obstet Gynecol (2004) 0.95
Fetal bradycardia due to intrathecal opioids for labour analgesia: a systematic review. BJOG (2002) 0.95
Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res (2005) 0.94
Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest (2002) 0.94
Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J Proteome Res (2013) 0.94
STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Am J Pathol (2012) 0.94
Absence of proteinase-activated receptor-1 signaling in mice confers protection from fMLP-induced goblet cell metaplasia. Am J Respir Cell Mol Biol (2009) 0.92
Home-based care after a shortened hospital stay versus hospital-based care postpartum: an economic evaluation. BJOG (2004) 0.91
Shooting for PARs in lung diseases. Curr Opin Pharmacol (2004) 0.91
Human papillomavirus self-sampling in Cameroon: women's uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis (2013) 0.91
A metabolomic study of preterm human and formula milk by high resolution NMR and GC/MS analysis: preliminary results. J Matern Fetal Neonatal Med (2012) 0.91
Metabolomics: a new era in cardiology? J Cardiovasc Med (Hagerstown) (2011) 0.90
Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Crit Rev Oncol Hematol (2009) 0.90
Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis (2002) 0.90
BAC consensus conference, November 4-6, 2004: epidemiology, pathogenesis, and preclinical models. J Thorac Oncol (2006) 0.90